Composition for freeze-drying menthol, freeze-dried menthol powder, and stick for dry powder inhaler comprising same

The freeze-drying of menthol with β-cyclodextrin and optional cryoprotectants addresses volatility issues, ensuring consistent menthol delivery in dry powder inhalers by stabilizing the flavor and simplifying production.

WO2026235409A1PCT designated stage Publication Date: 2026-11-12KT&G CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2026/095751
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2026-04-09
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Menthol's high volatility leads to significant loss during manufacturing and distribution of smoking products, causing variations in cooling sensation and increasing production costs due to complex methods like encapsulation and polymer mixing.

Method used

A composition for freeze-drying menthol using menthol and β-cyclodextrin, optionally with a cryoprotectant, to produce a uniform menthol freeze-dried powder suitable for dry powder inhalers.

Benefits of technology

The method stabilizes menthol, allowing easy storage and application in dry powder inhalers, maintaining consistent flavor and reducing manufacturing complexity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2026095751_12112026_PF_FP_ABST
    Figure KR2026095751_12112026_PF_FP_ABST
Patent Text Reader

Abstract

A composition for freeze-drying menthol, according to an embodiment, may comprise menthol and β-cyclodextrin. In addition, a freeze-dried menthol powder according to an embodiment may be obtained by freeze-drying a composition for freeze-drying menthol, comprising menthol and β-cyclodextrin. Furthermore, a stick for a dry powder inhaler, according to an embodiment, may comprise the above-described freeze-dried menthol powder.
Need to check novelty before this filing date? Find Prior Art

Description

Composition for freeze-drying menthol, freeze-dried menthol powder, and a stick for a dry powder inhaler containing the same

[0001] The embodiments relate to a composition for freeze-drying menthol, freeze-dried menthol powder, and a stick for a dry powder inhaler containing the same. More specifically, they are for preparing highly volatile menthol into freeze-dried powder.

[0002] Menthol is a representative flavoring substance added to smoking products, and it is an ingredient that changes the smoking experience by providing a unique coolness and refreshing scent.

[0003] However, menthol is highly volatile and tends to evaporate easily even at relatively low temperatures. Due to this volatility, menthol is lost during the manufacturing and distribution of smoking products, making it difficult to provide the intended cooling sensation and potentially causing variations between products depending on the storage environment.

[0004] To solve this, methods such as including menthol in capsules or mixing menthol with polymer materials to reduce volatility and control the release rate have been used, but there were problems such as high initial development costs, complex manufacturing processes, and poor versatility.

[0005] The embodiments provide a menthol freeze-drying composition and a menthol freeze-dried powder capable of producing highly volatile menthol in powder form to solve the aforementioned problems.

[0006] In addition, the present invention provides a menthol freeze-dried powder that may be included in a stick for a dry powder inhaler and a stick for a dry powder inhaler containing the same.

[0007] The problems to be solved through the embodiments are not limited to those described above, and problems not mentioned will be clearly understood by those skilled in the art to which the embodiments belong from this specification and the attached drawings.

[0008] A menthol freeze-drying composition according to one embodiment may include menthol and β-cyclodextrin.

[0009] A menthol freeze-dried powder according to one embodiment may be freeze-dried by including a menthol freeze-drying composition comprising menthol and beta-cyclodextrin.

[0010] A stick for a dry powder inhaler according to one embodiment may include the above-described menthol freeze-dried powder.

[0011] According to the menthol freeze-drying composition and menthol freeze-dried powder according to the embodiments, highly volatile menthol can be provided in powder form. According to the embodiments, menthol freeze-dried powder having a uniform formulation can be provided.

[0012] The menthol freeze-dried powder according to the embodiments is easy to store and can be easily applied to a stick for a dry powder inhaler.

[0013] The effects of the embodiments are not limited to the effects described above, and unmentioned effects will be clearly understood by those skilled in the art from this specification and the accompanying drawings.

[0014] FIG. 1 is a drawing showing the appearance of a stick for a dry powder inhaler according to one embodiment.

[0015] FIGS. 2a and 2b are drawings illustrating a stick for a dry powder inhaler according to embodiments.

[0016] FIG. 3 is a drawing illustrating a stick for a dry powder inhaler according to another embodiment.

[0017] FIG. 4 is a drawing illustrating a stick for a dry powder inhaler according to other embodiments.

[0018] FIG. 5a is a photograph taken after freeze-drying the composition of Example 1-1, and FIG. 5b is a photograph taken after freeze-drying the composition of Comparative Example 1-1.

[0019] The terms used in the embodiments have been selected based on currently widely used general terms whenever possible, taking into account their functions; however, these may vary depending on the intent of those skilled in the art, case law, or the emergence of new technologies. Additionally, in specific cases, the applicant has arbitrarily selected terms, and in such instances, their meanings will be described in detail in the relevant description of the invention. Therefore, the terms used in the embodiments must be defined not merely by their names, but based on their meanings and the overall context of the embodiments.

[0020] When a part of a specification is described as "comprising" a certain component, this means that, unless specifically stated otherwise, it does not exclude other components but may include additional components. Furthermore, terms such as "-part" or "-module" as used in the specification refer to a unit that processes at least one function or operation, and this may be implemented in hardware or software, or as a combination of hardware and software.

[0021] As used herein, when an expression such as "at least one" precedes an arranged component, it modifies the entire set of components rather than each individual component. For example, the expression "at least one of a, b, and c" should be interpreted as including a, b, and c, or a and b, a and c, b and c, or a, b, and c.

[0022] Embodiments of the present invention are described below with reference to the attached drawings so that those skilled in the art can easily implement them. However, the present invention may be embodied in various different forms and is not limited to the embodiments described herein.

[0023] Throughout the specification, embodiments are any classifications intended to facilitate the description of the invention, and each embodiment is not required to be mutually exclusive. For example, configurations disclosed in one embodiment may be applied and / or implemented in other embodiments and may be applied and / or implemented with modifications to the extent that they do not depart from the scope of the disclosure.

[0024] Furthermore, the terms used in this disclosure are for describing the embodiments and are not intended to limit the embodiments. In this disclosure, the singular form includes the plural form unless specifically stated otherwise.

[0025] Some components in the drawings may be depicted with their size or proportions slightly exaggerated. Additionally, components depicted in one drawing may not be depicted in another drawing.

[0026] Throughout the specification, the "length direction" of a component may be the direction in which the component extends along a unidirectional axis of the component, wherein the unidirectional axis of the component may mean the direction in which the component extends longer than the other unidirectional axis crossing the unidirectional axis. The "length direction" of a stick may mean the direction in which the length of the stick extends. Alternatively, it may mean the direction of the primary airflow through which air from the outside enters the user's mouth when the user inhales the stick.

[0027] For example, in FIG. 1, the longitudinal direction of the dry powder inhaler stick (100) may be the direction in which the shear section (110), the medium section (120), and the filter section (130) extend. That is, it may mean the height direction of the dry powder inhaler stick (100) in a cylindrical shape. In addition, the longitudinal direction of the dry powder inhaler stick (100) may coincide with the longitudinal direction of the medium section (120).

[0028] Additionally, when a user inhales air using a dry powder inhaler stick, the part where air enters from the outside to the inside of the dry powder inhaler stick may be referred to as "upstream," and the part where air exits from the inside to the outside of the dry powder inhaler stick may be referred to as "downstream." The terms "upstream" and "downstream" may be used to indicate the relative position or direction between parts or segments constituting the dry powder inhaler stick.

[0029] According to the examples, a composition for freeze-drying menthol can be provided that can produce highly volatile menthol in a uniform powder form while maintaining a constant yield. The composition for freeze-drying menthol according to the examples may include menthol and β-cyclodextrin.

[0030] Menthol is highly volatile, so a significant amount of flavor evaporates upon drying, making it difficult to manufacture in powder form; however, by freeze-drying using the menthol freeze-drying composition according to the example, a menthol freeze-dried powder having a uniform formulation can be produced. In addition, the menthol freeze-dried powder according to the example is easy to store.

[0031] According to the examples, the beta-cyclodextrin included in the composition for freeze-drying menthol may be in a hydrated form. When the hydrated beta-cyclodextrin is included in the composition for freeze-drying menthol and freeze-dried, a freeze-dried powder having a relatively high menthol yield and a uniform formulation can be produced.

[0032] According to the examples, menthol and beta-cyclodextrin may be included in a weight ratio of 1:3 to 1:10. If beta-cyclodextrin is used in an amount less than the range, menthol is not sufficiently included, and if beta-cyclodextrin is used in an amount greater than the range, the inclusion efficiency is lowered and the uniformity of the composition may be reduced.

[0033] According to the example, the menthol freeze-drying composition may comprise 1 to 5 weight% menthol, 3 to 50 weight% beta-cyclodextrin, 1 to 10 weight% ethanol, and the remainder being water, based on the total weight of the menthol freeze-drying composition.

[0034] If the beta-cyclodextrin is contained in an amount less than the above range, the freeze-dried powder may not be properly formed and the menthol yield may decrease, and if the beta-cyclodextrin is contained in an amount more than the above range, the freeze-drying time may increase and the overall process efficiency may decrease.

[0035] If the ethanol content is less than the above range, the menthol may not dissolve properly, and if the ethanol content is more than the above range, freeze-drying may not proceed smoothly and may cause a malfunction of the freeze-drying device.

[0036] According to another embodiment, a menthol freeze-drying composition may include menthol, β-cyclodextrin, and a cryoprotectant.

[0037] According to the examples, the cryoprotectant may be one or more selected from the group consisting of trehalose, mannitol, and xylitol. By including the cryoprotectant, the freeze-drying composition according to the examples can increase the powder yield and menthol yield.

[0038] According to the example, the cryoprotectant may be included in an amount of 0.1 to 2 weight percent based on the total weight of the menthol freeze-drying composition.

[0039] The menthol freeze-drying composition according to the example may comprise, based on the total weight of the menthol freeze-drying composition, 1 to 5 weight% of menthol, 3 to 50 weight% of beta-cyclodextrin, 0.1 to 2 weight% of cryoprotectant, 1 to 10 weight% of ethanol, and the remainder being water.

[0040] If the cryoprotectant is included in a smaller amount than the above range, the effect of increasing powder yield and menthol yield is negligible, and if the cryoprotectant is included in a larger amount than the above range, the freeze-drying time increases and the stability of the freeze-drying formulation may decrease.

[0041] According to the examples, a freeze-dried menthol powder may be provided, comprising a menthol freeze-drying composition according to the above-described examples.

[0042] In addition, through the embodiments, a stick for a dry powder inhaler (DPI) comprising the menthol freeze-dried powder described above may be provided. A dry powder inhaler is a device that allows nicotine powder (1% or less by weight) to be delivered directly to the user's airway by the user inhaling the dry powder, and may be manufactured as a stick in a shape similar to a smoking article.

[0043] The menthol freeze-dried powder according to the embodiment is easy to apply to a stick for a dry powder inhaler. A stick for a dry powder inhaler containing the menthol freeze-dried powder according to the embodiment can provide a menthol flavor when inhaled by a user.

[0044] Below, a stick for a dry powder inhaler according to embodiments is described in detail with reference to the attached drawings. However, it is not limited to the embodiments described herein.

[0045] FIG. 1 is a drawing showing the appearance of a stick (100) for a dry powder inhaler according to one embodiment.

[0046] A stick (100) for a dry powder inhaler according to an embodiment may include a shear section (110), a medium section (120), and a filter section (130).

[0047] Referring to FIG. 1, the shear section (110), the medium section (120), and the filter section (130) may be arranged sequentially along the length of the dry powder inhaler stick (100). That is, the medium section (120) may be positioned downstream of the shear section (110), and the filter section (130) may be positioned downstream of the medium section (120). In addition, other general-purpose components may be included in the dry powder inhaler stick (100) in addition to the components shown in FIG. 1.

[0048] The dry powder inhaler stick (100) according to the embodiment allows the user to inhale the dry powder by inhaling, just like a general smoking product. By the user contacting the end portion of the filter portion (130) located downstream of the medium portion (120) and inhaling, the dry powder contained inside the dry powder inhaler stick (100) can be inhaled into the user's mouth. When the user inhales the dry powder inhaler stick (100), the nicotine powder (121 in FIG. 2) contained in the medium portion (120) can be inhaled by the user, as described below.

[0049] The dry powder inhaler stick (100) according to the embodiment may have the shape of a general smoking article, but is not limited thereto. The dry powder inhaler stick (100) according to the embodiment can be simply manufactured using conventional smoking article manufacturing equipment.

[0050] The stick (100) for a dry powder inhaler according to the embodiment can easily inhale dry powder without a separate device. Therefore, it does not require a piercing structure or airflow design that was used in conventional dry powder inhalers.

[0051] The dry powder inhaler stick (100) may be manufactured in a cylindrical shape. In one embodiment, when the dry powder inhaler stick (100) is manufactured in a cylindrical shape, the diameter of the dry powder inhaler stick (100) may be about 5 mm to about 9 mm. The diameter of the dry powder inhaler stick (100) may refer to the diameter of the cylinder in a direction intersecting the length direction of the dry powder inhaler stick.

[0052] According to the embodiment, the length of the stick (100) for the dry powder inhaler may be about 20 mm to about 60 mm. For example, the length of the shear section (110) may be about 5 mm to about 15 mm, the length of the medium section (120) may be about 10 mm to about 30 mm, and the length of the filter section (130) may be about 5 mm to about 15 mm.

[0053] The dry powder inhaler stick (100) according to the embodiment can be manufactured to easily inhale dry powder with an inhalation pressure similar to that used when using a general smoking product. For example, when the dry powder inhaler stick (100) having the length and diameter described above is inhaled with a general inhalation pressure, about 35 ml to 55 ml of dry powder can be inhaled in 2 seconds.

[0054] In one embodiment, the dry powder inhaler stick (100) may have a length of about 44 mm to 52 mm, a diameter of about 6.5 mm to 8 mm, and a circumference of about 20 mm to 25 mm, and when inhaled with a normal suction pressure, a volume of about 35 ml to 55 ml may be inhaled in 2 seconds.

[0055] However, the length or diameter of the stick (100) for the dry powder inhaler and the elements constituting it are not limited to this and can be varied according to the design.

[0056] According to an embodiment, a stick (100) for a dry powder inhaler may include a shear section (110) upstream of a medium section (120). The shear section (110) can prevent the material contained in the medium section (120) from escaping to the outside.

[0057] The shear section (110) may include one of an acetate filter formed from cellulose acetate tow and a paper filter formed from paper. As an example, the shear section (110) may be manufactured by adding a plasticizer (e.g., triacetin) to cellulose acetate tow. The hardness of the shear section (110) can be adjusted by controlling the content of the plasticizer. Additionally, the shear section (110) may be implemented in various shapes as needed.

[0058] In the case where the shear section (110) includes an acetate filter formed from cellulose acetate tow, the shear section (110) can be manufactured to produce a flavor.

[0059] For example, if the shear section (110) includes an acetate filter, a flavoring liquid containing a flavoring substance may be sprayed onto the acetate filter, and a separate fiber coated with the flavoring liquid may be included inside the acetate filter. As another example, if the shear section (110) includes an acetate filter, the acetate filter may include a capsule containing the flavoring liquid. The flavoring substance is not limited to any substance that can be used in the dry powder inhaler stick (100).

[0060] According to an embodiment, the stick (100) for a dry powder inhaler may include a medium portion (120) downstream of the shear portion (110).

[0061] In one embodiment, the medium portion (120) may include nicotine powder as an inhalable dry powder. For example, the nicotine powder may be one or more selected from the group consisting of nicotine tartrate, nicotine aspartate, nicotine lactate, nicotine glutamate, nicotine bitartrate, nicotine salicylate, nicotine fumarate, nicotine mono-pyruvate, and nicotine hydrochloride.

[0062] Additionally, the medium (120) may contain inhalable substances in addition to nicotine powder. For example, it may contain other active ingredients (drugs).

[0063] In FIG. 1, the medium portion (120) is shown as a single segment, but is not limited thereto and can be formed as a plurality of segments.

[0064] According to an embodiment, the stick (100) for a dry powder inhaler may include a filter section (130) downstream of the medium section (120). The filter section (130) may be positioned opposite the shear section (110) with respect to the medium section (120).

[0065] The filter section (130) can be implemented in various shapes. For example, the filter section (130) may be a tube-shaped rod containing one hollow inside. It may also be a 3-hole filter containing two or more hollows, but is not limited thereto.

[0066] In one embodiment, the filter portion (130) may include an acetate filter formed from cellulose acetate tow. Additionally, the filter portion (130) may be manufactured to generate flavor. For example, when the filter portion (130) includes an acetate filter, a flavoring liquid containing a flavoring substance may be sprayed onto the acetate filter, and a separate fiber coated with said flavoring liquid may be included inside the acetate filter.

[0067] The flavoring material included in the filter section (130) may be the same or similar to the flavoring material that may be included in the aforementioned shear section (110). In one embodiment, one or more of the shear section (110) and the filter section (130) may include a flavoring material.

[0068] According to an embodiment, a stick (100) for a dry powder inhaler may include menthol freeze-dried powder in one or more of a shear section (110), a medium section (120), and a filter section (130).

[0069] FIGS. 2a and FIGS. 2b are drawings illustrating a stick (100) for a dry powder inhaler according to embodiments.

[0070] Referring to FIG. 2a, the medium portion (120) may contain nicotine powder (121) and menthol freeze-dried powder (150) inside.

[0071] When a user inhales the dry powder inhaler stick (100) according to the embodiment, the external air introduced through the front section (110) reaches the medium section (120), and the introduced external air passes through the filter section (130) together with the nicotine powder (121) and menthol freeze-dried powder (150) and can be delivered to the user's oral cavity.

[0072] According to an embodiment, the medium portion (120) may be formed by rolling paper into a circle to have an internal empty space. However, it is not limited thereto.

[0073] The rolled paper can form the outer surface of the medium portion (120), and the internal empty space can be formed along the longitudinal direction of the stick (100) for the dry powder inhaler. The paper forming the outer surface of the medium portion (120) may be a second wrapper (142) as described below.

[0074] When the paper is rolled into a circle to form an internal empty space, the internal space may be formed to have a hollow space in the shape of a tube with a circular cross-section. The formed internal space may contain nicotine powder (121) and menthol freeze-dried powder (150).

[0075] Meanwhile, according to one embodiment, a stick (100) for a dry powder inhaler can be packaged by at least one wrapper (140).

[0076] As an example, a dry powder inhaler stick (100) may be packaged by a single wrapper (140). As another example, a dry powder inhaler stick (100) may be packaged by two or more wrappers (140) in an overlapping manner. For example, the shear portion (110) may be packaged by a first wrapper (141), the medium portion (120) by a second wrapper (142), and the filter portion (130) by a third wrapper (143). Then, the entire dry powder inhaler stick (100) may be repackaged by a single final wrapper (144).

[0077] As described above, the second wrapper (142) may be paper that is rolled up to form the outer surface of the medium portion (120) and the internal empty space. However, the shape of the medium portion (120) is not limited thereto.

[0078] The first wrapper (141), the second wrapper (142), and the third wrapper (143) may be made of general filter paper. For example, the first wrapper (141), the second wrapper (142), and the third wrapper (143) may be porous paper or non-porous paper. Additionally, the first wrapper (141), the second wrapper (142), and the third wrapper (143) may be made of oil-resistant paper and / or aluminum laminate packaging materials.

[0079] For example, the first wrapper (141) may be made of oil-resistant hard paper. For example, the shear section (110) may include at least one capsule. The capsule may perform the function of generating flavor. For example, the capsule may be a structure in which a liquid containing flavoring is wrapped in a film. The capsule may have a spherical or cylindrical shape, but is not limited thereto. When the shear section (110) includes the capsule described above, the first wrapper (141) may be made of oil-resistant hard paper.

[0080] Meanwhile, the final wrapper (144) may use specially manufactured paper that reduces contamination of the outer surface of the dry powder inhaler stick (100) while preventing contaminated material from seeping inside.

[0081] As an example, the final wrapper (144) may be made of sterile paper (MFW). Sterile paper (MFW) refers to paper specially manufactured to improve tensile strength, water resistance, smoothness, etc., compared to ordinary paper.

[0082] As another example, a specific material may be added to the final wrapper (144). Examples of such a specific material may include silicone, but are not limited thereto. For example, silicone has properties such as heat resistance with minimal change with temperature, oxidation resistance that does not oxidize, resistance to various chemicals, water repellency, or electrical insulation. However, even if it is not silicone, any material having the aforementioned properties may be applied (or coated) to the final wrapper (144) without limitation.

[0083] Referring to FIG. 2b, the medium portion (120) may be formed with two segments. Although not illustrated, the medium portion (120) may include two or more segments.

[0084] Referring to FIG. 2b, the dry powder inhaler stick (100) sequentially includes a shear section (110), a first medium section (120a), a second medium section (120b), and a filter section (130).

[0085] In one embodiment, the medium portion (120) may include nicotine powder (121) in one segment and menthol freeze-dried powder (150) in the other segment. As shown in FIG. 2b, the first medium portion (120a) may include menthol freeze-dried powder (150) and the second medium portion (120b) may include nicotine powder (121). Although not illustrated, conversely, the first medium portion (120a) may include nicotine powder (121) and the second medium portion (120b) may include menthol freeze-dried powder (150).

[0086] In another embodiment, the medium portion (120) may include powders of different compositions for each segment. For example, the medium portion (120) may include different amounts of nicotine powder (121) and menthol freeze-dried powder (150) depending on the segment. As an example, by including more nicotine powder (121) and menthol freeze-dried powder (150) in the second medium portion (120b) than the amount of nicotine powder (121) and menthol freeze-dried powder (150) in the first medium portion (120a), the amount of nicotine powder (121) and menthol freeze-dried powder (150) inhaled through initial inhalation can be increased. However, it is not limited thereto and can be appropriately arranged according to the amount intended for inhalation.

[0087] In another embodiment, the medium portion (120) may contain equal amounts of nicotine powder (121) and menthol freeze-dried powder (150) in each segment.

[0088] According to an embodiment, the first medium portion (120a) may be wound by a seconda wrapper (142a), and the second medium portion (120b) may be wound by a secondb wrapper (142b). Although not illustrated, as another example, a single wrapper surrounding the first medium portion (120a) and the second medium portion (120b) may be included.

[0089] FIG. 3 is a drawing illustrating a stick (100) for a dry powder inhaler according to another embodiment.

[0090] According to an embodiment, the medium portion (120) of the dry powder inhaler stick (100) comprises nicotine powder (121), and one or more of the shear portion (110) and filter portion (130) may comprise menthol freeze-dried powder (150).

[0091] According to one embodiment, with reference to FIG. 3, a stick (100) for a dry powder inhaler may include nicotine powder (121) in a medium portion (120) and menthol freeze-dried powder (150) in a filter portion (130). As another example not illustrated, the medium portion (120) may include nicotine powder (121) and the front portion (110) may include menthol freeze-dried powder (150).

[0092] According to the embodiment, the menthol freeze-dried powder (150) included in one or more of the shear section (110) and the filter section (130) may be sprinkled onto a cellulose acetate tow forming an acetate filter, or may be included in a capsule in powder form and contained inside one or more of the shear section (110) and the filter section (130). The shell of the capsule may be crushed by pressure. Alternatively, the menthol freeze-dried powder (150) according to the embodiment may be applied to the outer surface of one or more of the shear section (110) and the filter section (130). However, the form in which the menthol freeze-dried powder (150) is included is not limited thereto.

[0093] When menthol is applied in powder form, it can be applied more easily to a dry powder inhaler stick (100) than to a liquid flavoring material. In addition, when a liquid flavoring material is included in a capsule, etc., it is necessary to apply an oil-resistant paper to reduce the wrapping material from wetting the wrapper, but according to the embodiment, the need to apply an oil-resistant paper is reduced, thereby simplifying the manufacturing process and reducing manufacturing costs.

[0094] According to the embodiment, the menthol freeze-dried powder (150) is included in one or more of the shear section (110) and filter section (130) separately from the nicotine powder (121) included in the medium section (120), thereby having the advantage of being easy to manufacture and easy to store.

[0095] FIG. 4 is a drawing illustrating a stick (100) for a dry powder inhaler according to other embodiments.

[0096] According to an embodiment, menthol freeze-dried powder (150) can be applied to a wrapper (140). In one embodiment, menthol freeze-dried powder (150) can be applied to the inner surface of the wrapper (140) that comes into contact with the shear portion (110), the medium portion (120), and the filter portion (130) when the wrapper (140) surrounds the shear portion (110), the medium portion (120), and the filter portion (130).

[0097] Referring to FIG. 4, the menthol freeze-dried powder (150) may be applied to the inner surface of the second wrapper (142) surrounding the medium portion (120). However, not limited thereto, the menthol freeze-dried powder (150) may be applied to the inner surface of the first wrapper (141) surrounding the shear portion (110). Alternatively, the menthol freeze-dried powder (150) may be applied to the inner surface of the third wrapper (143) surrounding the filter portion (130). Alternatively, the menthol freeze-dried powder (150) may be applied to the inner surface of the final wrapper (144) surrounding the first wrapper (141), the second wrapper (142), and the third wrapper (143). Additionally, it may be applied in a combined form of the above-described embodiments.

[0098] In another embodiment, menthol freeze-dried powder (150) may be applied to the outer surface of the wrapper (140) that forms the outer surface of the shear portion (110), medium portion (120), and filter portion (130) when the wrapper (140) surrounds the shear portion (110), medium portion (120), and filter portion (130).

[0099] Although not illustrated, for example, the menthol freeze-dried powder (150) may be applied to the outer surface of the first wrapper (141) surrounding the shear portion (110), in which case the menthol freeze-dried powder (150) is positioned between the first wrapper (141) and the final wrapper (144). Alternatively, the menthol freeze-dried powder (150) may be applied to the outer surface of the second wrapper (142) surrounding the medium portion (120), in which case the menthol freeze-dried powder (150) is positioned between the second wrapper (142) and the final wrapper (144). Alternatively, the menthol freeze-dried powder (150) may be applied to the outer surface of the third wrapper (143) surrounding the filter portion (130), in which case the menthol freeze-dried powder (150) is positioned between the third wrapper (143) and the final wrapper (144). Alternatively, the menthol freeze-dried powder (150) may be applied to the outer surface of the final wrapper (144). In addition, it may be applied in a combined form of the above-described embodiments.

[0100] All embodiments described above in this specification may be combined with each other.

[0101] The invention will be explained in more detail below through examples and experimental examples. These examples are merely illustrative, and it will be obvious to those skilled in the art that the invention is not to be interpreted as being limited by these examples.

[0102] <Example>

[0103] 1. Experimental Example 1-1: Comparative Experiment of Menthol Freeze-Dried Powder Formulations

[0104] A composition for freeze-drying menthol was prepared using β-Cyclodextrin and Maltodextrin, respectively, and an experiment was conducted to determine whether it could be produced into a powder formulation by performing a freeze-drying process. A composition for freeze-drying was prepared by mixing β-Cyclodextrin (hydrate, 99.0%, SAMCHUN, Gyeonggi-do, Korea) and Maltodextrin (Sigma-Aldrich, Seoul, Korea), respectively, with menthol (L-Menthol, DAEHUNG, Seoul, Korea), and then a freeze-drying process was applied.

[0105] The composition of Example 1-1 containing β-Cyclodextrin was prepared according to the composition of Table 1 below.

[0106] Ingredients (Weight%) Example 1-1 β-Cyclodextrin 15 Menthol 3 Ethanol 5 Distilled Water 77 Total 100

[0107] Separately, the composition of Comparative Example 1-1 containing Maltodextrin was prepared according to the composition of Table 2 below, and a formulation comparison experiment for the preparation of freeze-dried powder was conducted.

[0108] Ingredients (Weight%) Comparative Example 1-1 Maltodextrin 15 Menthol 3 Ethanol 5 Distilled Water 77 Total 100

[0109]

[0110] For Example 1-1, β-Cyclodextrin was added to distilled water at 50 °C and homogenized at 400 rpm for 1 hour. Menthol was dissolved in an ethanol solution and then mixed with the β-Cyclodextrin solution. Subsequently, the mixed composition was placed in a deep freezer (FDE60086FD, FORMA TMThe sample was frozen at -45°C for 24 hours using a Thermo Fisher Scientific (HyperCOOL 3110, Labogene) and then dried at -45°C for 72 hours. Freeze-drying was performed using a cold trap (HyperCOOL 3110, Labogene) with a 4 L capacity chamber and internal dimensions of φ30 × 40 cm, and a rotary vane pump (W2V20, WSA, Gyeonggi-do, Korea) was used as the vacuum pump. During the freeze-drying process, changes in sample weight were recorded in real-time using a digital balance installed in the vacuum chamber, spread out, and utilized to calculate the drying rate.

[0111] In the case of Comparative Example 1-1, a composition was prepared including Maltodextrin instead of β-Cyclodextrin and the same freeze-drying process was applied.

[0112] As a result of freeze-drying, it was confirmed that in the case of Example 1-1, the final powder produced exhibited a uniform formulation and air-floating characteristics suitable for inhalation (see Fig. 5a). On the other hand, in the case of Comparative Example 1-1, it was confirmed that clumping occurred because the drying of the powder was incomplete (see Fig. 5b). Therefore, it was confirmed that Comparative Example 1-1, in which Maltodextrin was applied to the menthol freeze-drying composition, is unsuitable for manufacturing menthol freeze-dried powder for inhalation.

[0113]

[0114] 2. Experimental Example 1-2: Yield Comparison Experiment of β-Cyclodextrin Depending on Hydration

[0115] A comparative experiment on powder yield and menthol yield was conducted by carrying out a freeze-drying process using a freeze-drying composition containing hydrated β-Cyclodextrin and unhydrated β-Cyclodextrin.

[0116] Example 1-1 is a composition for freeze-drying menthol containing hydrated β-Cyclodextrin. Comparative Example 1-2 is a composition for freeze-drying menthol prepared by replacing the hydrated β-Cyclodextrin of Example 1-1 with unhydrated β-Cyclodextrin. After freeze-drying using the compositions of Example 1-1 and Comparative Example 1-2, the powder yield and menthol yield were measured.

[0117] The powder and menthol yields were calculated as the ratio of the sample solids after freeze-drying to the sample solids after initial input, as shown in Equation 1 below.

[0118] [Mathematical Formula 1]

[0119]

[0120] (S r : Final solid weight S after freeze-drying t : Initial input solid weight)

[0121]

[0122] Using the above mathematical formula 1, the powder yield was calculated by measuring the weight of the initial input solids excluding the solvent and the weight of the powder after freeze-drying. In addition, the menthol yield was calculated by measuring the weight of the initial input menthol and the weight of menthol in the powder after freeze-drying. The weight of menthol in the powder after freeze-drying was quantitatively analyzed by gas chromatography (Agilent GC6890, Agilent Technologies) after dissolving the powder in methanol. The menthol content was analyzed after adding the freeze-dried menthol powder to methanol and shaking it at 200 rpm for 1 hour using a shaker.

[0123] The measurement results are shown in Table 3 below.

[0124] Yield (%) Example 1-1 Comparative Example 1-2 Powder yield 84.33 85.68 Menthol yield 62.40 52.60

[0125]

[0126] As a result of measurement, it was confirmed that the freeze-dried powder prepared using the freeze-drying composition containing hydrated β-Cyclodextrin (Example 1-1) showed a significantly higher menthol yield compared to the freeze-drying powder prepared using the freeze-drying composition containing unhydrated β-Cyclodextrin (Comparative Example 1-2).

[0127]

[0128] 3. Experimental Example 2-1: Yield Comparison Experiment Depending on the Addition of Cryoprotectant

[0129] Freeze-dried powders were prepared using trehalose, mannitol, and xylitol as cryoprotectants, and the powder yield and menthol yield were compared.

[0130] As in Experimental Example 1-1 above, a composition containing menthol (L-Menthol, DAEHUNG, Seoul, Korea) and β-Cyclodextrin (hydrate, 99.0%, SAMCHUN, Gyeonggi-do, Korea) according to the ratios in Table 4 was prepared as Example 1-1, and compositions containing Trehalose, Mannitol, and Xylitol, respectively, were prepared as Examples 2-1 to 2-3, respectively, in addition to the composition of Example 1-1, and then a freeze-drying process was applied.

[0131] The composition of each composition is as shown in Table 4 below.

[0132] Ingredients (Weight%) Example 1-1 Example 2-1 Example 2-2 Example 2-3 β-Cyclodextrin 15 14 14 14 Cryoprotectant 1.5 1.5 1.5 Menthol 3 3 3 Ethanol 5 4.5 4.5 4.5 Distilled Water 7 7 7 7 7 7 7 Total 1 0 1 0 1 0 1 0 1 0

[0133]

[0134] As shown in the composition of Table 4 above, β-Cyclodextrin was added to distilled water at 50°C and homogenized at 400 rpm for 1 hour. Menthol was dissolved in an ethanol solution and then mixed with the β-Cyclodextrin solution to prepare the menthol freeze-drying composition of Example 1-1.

[0135] Meanwhile, β-Cyclodextrin was added to distilled water at 50°C and homogenized at 400 rpm for 1 hour. Menthol was dissolved in an ethanol solution, a cryoprotectant was added, and the mixture was combined with the β-Cyclodextrin solution to prepare the compositions for menthol freezing of Examples 2-1 to 2-3. Compositions were prepared using Trehalose as the cryoprotectant in Example 2-1, using Mannitol in Example 2-2, and using Xylitol in Example 2-3.

[0136] Subsequently, the compositions of Example 1-1 and Examples 2-1 to 2-3 were used in a deep freezer (FDE60086FD, FORMA TM The sample was frozen at -45°C for 24 hours using a Thermo Fisher Scientific cold trap, followed by drying at -45°C for 72 hours. Freeze-drying was performed using a cold trap (HyperCOOL 3110, Labogene) with a 4 L capacity chamber and internal dimensions of φ30 × 40 cm, and a rotary vane pump (W2V20, WSA, Gyeonggi-do, Korea). During the freeze-drying process, changes in sample weight were recorded in real-time using a digital balance installed in the vacuum chamber and spread out to be used for calculating the drying rate.

[0137] After freeze-drying using the compositions of Example 1-1 and Examples 2-1 to 2-3, the powder yield and menthol yield were measured. The powder and menthol yields were calculated as the ratio of the sample solid after freeze-drying to the sample solid after initial input, as shown in Equation 1 of Experimental Example 1-2.

[0138] Using the above mathematical formula 1, the powder yield was calculated by measuring the weight of the initial input solids excluding the solvent and the weight of the powder after freeze-drying. In addition, the menthol yield was calculated by measuring the weight of the initial input menthol and the weight of menthol in the powder after freeze-drying. The weight of menthol in the powder after freeze-drying was quantitatively analyzed by gas chromatography (Agilent GC6890, Agilent Technologies) after dissolving the powder in methanol. The menthol content was analyzed after adding the freeze-dried menthol powder to methanol and shaking it with a shaker at 200 rpm for 1 hour.

[0139] The measurement results are shown in Table 5 below.

[0140] Yield (%) Example 1-1 Example 2-1 Example 2-2 Example 2-3 Powder yield 84.33 89.30 90.92 86.83 Menthol yield 62.40 70.60 77.70 68.40

[0141]

[0142] As a result of the experiment, it was found that Examples 2-1 to 2-3 containing a cryoprotectant showed high powder yield and menthol yield.

[0143] In addition, among them, Example 2-2, which used Mannitol as a cryoprotectant, showed the highest powder yield at 90.92% and menthol yield at 77.70%. In addition, Example 2-1, which used Trehalose as a cryoprotectant, showed the next highest powder yield at 89.30% and menthol yield at 70.60%.

[0144]

[0145] 4. Experimental Example 2-2: Experiment Comparing Menthol Yield According to Cryoprotectant Content

[0146] The powder yield and menthol yield were compared by adjusting the content of the cryoprotectant. The compositions of Comparative Examples 2-1 to 2-3 were prepared by adjusting the content of Trehalose and Mannitol, which yielded high powder yield and menthol yield, respectively, and then freeze-dried.

[0147] Comparative Example 2-1 contains 2.5 wt% of Trehalose as a cryoprotective agent, Comparative Example 2-2 contains 2.5 wt% of Mannitol as a cryoprotective agent, and Comparative Example 2-3 contains 1.25 wt% each of Trehalose and Mannitol as cryoprotective agents. The composition of each composition is as shown in Table 6 below.

[0148] Ingredients (Weight%) Example 2-1 Example 2-2 Comparative Example 2-1 Comparative Example 2-2 Comparative Example 2-3 β-Cyclodextrin 14 14 13 13 13 Cryoprotectant Mannitol 1.5-2.5 1.25 Trehalose 1.5-2.5-1.25 Menthol 3 3 3 3 Ethanol 4.5 4.5 4.5 4.5 4.5 Distilled Water 7 7 7 7 7 7 7 7 Total 1 0 1 0 1 0 1 0 1 0 1 0 0

[0149]

[0150] The measurement results of powder yield and menthol yield for the above Examples 2-1, 2-2 and Comparative Examples 2-1 to 2-3 are shown in Table 7 below.

[0151] Yield (%) Example 2-1 Example 2-2 Comparative Example 2-1 Comparative Example 2-2 Comparative Example 2-3 Powder yield 89.30 90.9 290.05 88.8 184.65 Menthol yield 70.60 77.70 50.00 51.70 52.80

[0152]

[0153] As a result of the experiment, it was confirmed that the menthol yield was significantly reduced in Comparative Examples 2-1 to 2-3, which contain 2.5% by weight of cryoprotectant, compared to Examples 2-1 and 2-2, which contain 1.5% by weight of cryoprotectant based on the total weight of the freeze-dried composition.

[0154] In addition, it was confirmed that in the case of Comparative Examples 2-1 to 2-3, the menthol yield was reduced compared to Example 1-1, which did not contain a cryoprotectant.

[0155] The description of the embodiments described above is merely illustrative, and those skilled in the art will understand that various modifications and equivalent alternative embodiments are possible therefrom. Accordingly, the true scope of protection of the invention should be determined by the appended claims, and all variations within the scope equivalent to that described in the claims should be interpreted as being included within the scope of protection determined by the claims.

Claims

1. A composition for freeze-drying menthol comprising menthol and β-cyclodextrin.

2. In Paragraph 1, A composition for freeze-drying menthol, comprising the menthol and the beta-cyclodextrin in a weight ratio of 1:3 to 1:

10.

3. In Paragraph 1, Based on the total weight of the above menthol freeze-drying composition, The above menthol freeze-drying composition comprises 1% to 5% by weight of the menthol, 3% to 50% by weight of the beta-cyclodextrin, 1% to 10% by weight of ethanol, and the remainder being water.

4. In Paragraph 1, The above beta-cyclodextrin is a hydrated form, a composition for freeze-drying menthol.

5. In Paragraph 1, The above menthol freeze-drying composition further comprises a cryoprotectant.

6. In Paragraph 5 The above cryoprotective agent is one or more selected from the group consisting of trehalose, mannitol, and xylitol, a composition for menthol freeze-drying.

7. In Paragraph 5, The above cryoprotectant is included in a menthol freeze-drying composition in an amount of 0.1% to 2% by weight based on the total weight of the menthol freeze-drying composition.

8. A freeze-dried menthol powder comprising a menthol freeze-drying composition comprising menthol and beta-cyclodextrin.

9. In Paragraph 8, The above menthol freeze-dried powder is a menthol freeze-dried powder further comprising a cryoprotectant.

10. A stick for a dry powder inhaler comprising the menthol freeze-dried powder of claim 8 or 9.

11. In Paragraph 10, The above dry powder inhaler stick is, It includes a shear section, a medium section, and a filter section based on the longitudinal direction, A stick for a dry powder inhaler, comprising the above medium portion nicotine powder and the above menthol freeze-dried powder.

12. In Paragraph 11, The above medium comprises two or more segments, and A stick for a dry powder inhaler, comprising the nicotine powder in one segment and the menthol freeze-dried powder in another segment.

13. In Paragraph 10, The above dry powder inhaler stick is, It includes a shear section, a medium section, and a filter section based on the longitudinal direction, The above medium part includes nicotine powder, and A stick for a dry powder inhaler, wherein one or more of the above-mentioned shear section and the above-mentioned filter section comprise the above-mentioned freeze-dried menthol powder.

14. In Paragraph 10, The above dry powder inhaler stick is, It includes a shear section, a medium section, and a filter section based on the longitudinal direction, A stick for a dry powder inhaler, comprising a wrapper coated with menthol freeze-dried powder, surrounding one or more of the shear portion, the medium portion, and the filter portion.